X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.indianpharmapost.com/news/biocon-receives-approval-from-sahpra-for-tacrolimus-capsule-15548
https://www.reuters.com/business/healthcare-pharmaceuticals/indias-biocon-developing-its-own-version-wegovy-clinical-trial-likely-next-year-2024-04-18/
https://economictimes.indiatimes.com/industry/healthcare/biotech/biocon-partners-biomm-to-commercialise-diabetes-drug-in-brazil/articleshow/109379384.cms
https://www.business-standard.com/companies/news/biocon-leads-india-s-push-into-anti-obesity-drugs-as-patents-lapse-124040800028_1.html
https://www.indianpharmapost.com/drug-approval/biocon-to-obtain-approval-for-diabetes-drug-liraglutide-in-uk-15447
https://www.reuters.com/markets/deals/indias-biocon-sell-branded-formulations-business-eris-lifesciences-150-mln-2024-03-14/
https://www.reuters.com/business/healthcare-pharmaceuticals/compounded-semaglutide-poses-serious-us-health-issue-novo-nordisk-ceo-says-2024-03-08/
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/biocon-gets-over-rs-3-crore-penalty-over-gst-related-issues/articleshow/107944322.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/biocon-cfo-indranil-sen-resigns/articleshow/107531559.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
https://www.reuters.com/business/healthcare-pharmaceuticals/indias-biocon-posts-profit-biosimilar-boost-divestment-gains-cfo-resigns-2024-02-08/
Market Place
Share 
